On May 22, our General Director Bernard Mulder had the honor of joining His Majesty King Willem-Alexander of the Kingdom of the Netherlands, Prof. Yoshiki Sawa, Chairman of the Organization for Advanced Healthcare Innovation (Nakanoshima Qross), and H.E. Ms. Reinette Klever, Minister for Foreign Trade and Development Cooperation of the Netherlands.

We’re proud to share Frank Luyten his reflections in this original column, published by FAST and republished here by RegMed XB with permission.

As part of RegMed XB’s diabetes moonshot, researchers at the Leiden University Medical Center (LUMC) have developed a method to enhance the purity of insulin-producing islets, grown from stem cells in the laboratory. While originally aimed at diabetes, this technique has broader implications and could be applied to various stem cell-based therapies.